Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy-Reference-Cited by-同舟云学术

Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy

Published:2018-11 Issue:5 Volume:52 Page:643-650
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Carreno Joseph^ORCID,Smiraglia Tori,Hunter Christopher,Tobin Ellis,Lomaestro Ben

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference42 articles.

1. Prevalence of antimicrobial use in US acute care hospitals, May–September 2011;Magill;JAMA,2014

2. Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012;Baggs;JAMA Intern Med,2016

3. Vancomycin-associated renal dysfunction: where are we now?;Carreno;Pharmacotherapy,2014

4. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists;Rybak;Clin Infect Dis,2009

5. Relationship between initial vancomycin concentration–time profile and nephrotoxicity among hospitalized patients;Lodise;Clin Infect Dis,2009

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum concentration of continuously administered vancomycin influences efficacy and safety in critically ill adults: a systematic review;International Journal of Antimicrobial Agents;2023-12

2. Application of ultrasound microbubble contrast to evaluate the effect of sitaxentan on renal microvascular perfusion in beagles undergoing cardiopulmonary bypass;Clinical Hemorheology and Microcirculation;2023-10-30

3. Assessing Clinical Outcomes of Vancomycin Treatment in Adult Patients with Vancomycin-Susceptible Enterococcus faecium Bacteremia;Antibiotics;2023-10-29

4. Piperacillin-Tazobactam Versus Anti-Pseudomonal Cephalosporins and Renal and Neurologic Outcomes in Critically Ill Adults: A Secondary Analysis of the SMART Trial;Journal of Intensive Care Medicine;2023-06-26

5. Efficacy and Safety of Continuous Infusion of Vancomycin in Critically Ill Adults: A Systematic Review;2022-10-21